Form 4: Procter & Gamble Executive Jennifer L. Davis Reports Stock Transactions
SEC Form 4 Filing
Jennifer L. Davis, CEO Health Care at Procter & Gamble, reports the acquisition and disposal of company stock and stock options.
Summary
- On October 2, 2024, Jennifer L. Davis sold 4,447 shares of Procter & Gamble common stock at a price of $171.6541 per share.
- Following this transaction, Ms. Davis directly owns 52,872.0851 shares of common stock.
- She also indirectly owns 14,498.0702 shares through a retirement plan trustee.
- On October 1, 2024, Ms. Davis acquired 56,554 stock options with an exercise price of $173.04, exercisable from October 1, 2027, to September 29, 2034.
- Following this transaction, Ms. Davis directly owns 56,554 stock options.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of stock option acquisition |
| 10/02/2024 | Date of common stock sale |
| 10/03/2024 | Date of signature on the form |
| 10/01/2027 | Earliest date stock options are exercisable |
| 09/29/2034 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.